Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha lipoic acid for dementia.

J Sauer1, N Tabet, R Howard

  • 1Section of Old Age Psychiatry, Institute of Psychiatry, De Crespigny Park, London, UK, SE5 8AF.

The Cochrane Database of Systematic Reviews
|February 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Definition of treatment-resistant late-life depression: Conclusions from a European Task Force Delphi process.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Longitudinal associations of psychological distress with subsequent cognitive decline and dementia: a multi-cohort study.

medRxiv : the preprint server for health sciences·2025
Same author

LILAC - An Integrated Approach to Diagnosis and Intervention in Autism Spectrum Disorder.

Irish medical journal·2024
Same author

Human and machine-induced social stress in complex work environments: Effects on performance and subjective state.

Applied ergonomics·2023
Same author

Time on task and task load in visual inspection: A four-month field study with X-ray baggage screeners.

Applied ergonomics·2023
Same author

Cancer Decedents' Hospital End-of-Life Care Documentation: A Retrospective Review of Patient Records.

Journal of palliative care·2023
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

No clinical trials were found to evaluate alpha lipoic acid (ALA) for dementia treatment. Therefore, current evidence does not support ALA

Area of Science:

  • Neuroscience
  • Pharmacology
  • Gerontology

Background:

  • Oxidative stress contributes to neurodegenerative diseases like Alzheimer's.
  • Alpha lipoic acid (ALA) is an endogenous antioxidant with potential neuroprotective properties.
  • ALA's antioxidant activity may offer therapeutic benefits for dementia.

Purpose of the Study:

  • To evaluate the clinical efficacy of alpha lipoic acid (ALA) in treating dementia.
  • To assess the role of ALA as a therapeutic agent for cognitive decline.

Main Methods:

  • Systematic search of the Cochrane Dementia and Cognitive Improvement Group (CDCIG) Specialized Register.
  • Inclusion criteria: double-blind, randomized, placebo-controlled trials of ALA for dementia.
  • Searched databases: MEDLINE, EMBASE, PsycInfo, CINAHL, and trials databases.

Related Experiment Videos

Main Results:

  • No trials met the selection criteria for inclusion.
  • A meta-analysis could not be performed due to the absence of relevant studies.
  • No studies investigating ALA for dementia were identified in the systematic search.

Conclusions:

  • There is currently no evidence to support the use of alpha lipoic acid for dementia.
  • Further randomized, double-blind, placebo-controlled trials are needed to determine ALA's efficacy.
  • ALA cannot be recommended for dementia patients until supporting trial data becomes available.